A comparative analysis of glycemic metrics derived from three continuous glucose monitoring systems
Freckmann G, Wehrstedt S, Eichenlaub M, et al.
Diabetes Care. 2025:dc250129.
Leggi
Breaking news
Oral semaglutide and cardiovascular outcomes in persons with type 2 diabetes, according to SGLT2i use: prespecified analyses of the SOUL randomized trial
Marx N, Deanfield JE, Mann JFE, et al.
Circulation. Pub. online 29 Mar 2025.
Leggi
Parent-of-origin effects in the life-course evolution of cardiometabolic traits
Wagh R, Hatem G, Andersson J, et al.
Diabetologia. Pub. online 2 Apr 2025.
Leggi
Comparison of dose escalation versus switching to tirzepatide among people with type 2 diabetes inadequately controlled on lower doses of dulaglutide : a randomized clinical trial
Billings LK, Winne L, Sharma P, et al.
Ann Intern Med. Pub. online 2 Apr 2025.
Leggi
Combination of glucagon-like peptide 1 receptor agonist and thiazolidinedione for mortality and cardiovascular outcomes in patients with type 2 diabetes
Li JX, Hsu TJ, Lin HJ, et al.
JAMA Netw Open. 2025;8(3):e252577.
Leggi
A narrative review of metformin in pregnancy: navigating benefit and uncertainty
McEvoy RP, Newman C, Egan AM, Dunne FP
Diabetes Obes Metab. Pub. online 2 Apr 2025.
Leggi
Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes
Hanif M, Hays AG, Nagarajan JS, et al.
Am J Cardiol. 2025;246:10-13.
Leggi
An oral PCSK9 inhibitor for treatment of hypercholesterolemia: the pursuit randomized trial
Koren MJ, Vega RB, Agrawal N, et al.
J Am Coll Cardiol. Pub. online 27 Mar 2025.
Leggi
Lack of validity of the glucose management indicator in type 1 diabetes in pregnancy
Meek CL, Feig DS, Scott EM, et al.
Diabetes Care. 2025 Apr 2:dc242494.
Leggi
Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials
Lee MMY, Sattar N, Pop-Busui R, et al.
Diabetes Care. 2025:dc250241.
Leggi